Cargando…

Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis

Inflammatory bowel diseases (IBDs) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical practice; however, it is a costly, time-consuming, invasive, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldan-Martin, Montse, Chaparro, María, Gisbert, Javier P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299330/ https://www.ncbi.nlm.nih.gov/pubmed/37373307 http://dx.doi.org/10.3390/ijms241210159

Ejemplares similares

Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease
por: Soleto, Irene, et al.
Publicado: (2023)

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
por: Aldars-García, Laila, et al.
Publicado: (2021)

Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
por: Aldars-García, Laila, et al.
Publicado: (2021)

Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis
por: Guberna, Laura, et al.
Publicado: (2021)

The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
por: Aldars-García, Laila, et al.
Publicado: (2021)

Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?
por: Gisbert, Javier P., et al.
Publicado: (2021)

Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2021)

Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2020)

Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease
por: Fernández-Tomé, Samuel, et al.
Publicado: (2019)

Differential Effects of Anti-TNFα and Anti-α4β7 Drugs on Circulating Dendritic Cells Migratory Capacity in Inflammatory Bowel Disease
por: Soleto, Irene, et al.
Publicado: (2022)

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease
por: Bauset, Cristina, et al.
Publicado: (2021)

The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU
por: Chaparro, María, et al.
Publicado: (2021)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis
por: Sun, Lina, et al.
Publicado: (2022)

Biomarker discovery in inflammatory bowel diseases using network-based feature selection
por: Abbas, Mostafa, et al.
Publicado: (2019)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies
por: Rubín de Célix, Cristina, et al.
Publicado: (2022)

Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment
por: Norouzinia, Mohsen, et al.
Publicado: (2017)

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience
por: Barreiro‐de Acosta, Manuel, et al.
Publicado: (2021)

Serum adipokines as non-invasive biomarkers in Crohn’s disease
por: Ortega Moreno, Lorena, et al.
Publicado: (2020)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
por: Chaparro, María, et al.
Publicado: (2019)

Urine metabolome profiling of immune-mediated inflammatory diseases
por: Alonso, Arnald, et al.
Publicado: (2016)

Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
por: Delicata, Nicholas-Paul, et al.
Publicado: (2016)

Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
por: Izquierdo-Garcia, José Luis, et al.
Publicado: (2020)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

Biomarkers and Hematological Indices in the Diagnosis of Iron Deficiency in Children with Inflammatory Bowel Disease
por: Krawiec, Paulina, et al.
Publicado: (2020)

Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Systematic review—pancreatic involvement in inflammatory bowel disease
por: Massironi, Sara, et al.
Publicado: (2022)

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
por: Gisbert, Javier P., et al.
Publicado: (2023)

Systematic review: genetic biomarkers associated with anti‐TNF treatment response in inflammatory bowel diseases
por: Bek, S., et al.
Publicado: (2016)

Pursuing neutrophils: systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease
por: Magalhaes, Diogo, et al.
Publicado: (2023)

Antidepressants and inflammatory bowel disease: a systematic review
por: Mikocka-Walus, Antonina A, et al.
Publicado: (2006)

Alexithymia and Inflammatory Bowel Disease: A Systematic Review
por: Martino, Gabriella, et al.
Publicado: (2020)

Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
por: Sakurai, Toshiyuki, et al.
Publicado: (2023)

Comparison of the amniotic fluid and fetal urine peptidome for biomarker discovery in renal developmental disease
por: Fédou, Camille, et al.
Publicado: (2020)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017)

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eogcf64mitan0avsmu2a00cn1r